Skip to main content
LMAT logo

LMAT

Lemaitre Vascular Inc
$105.70 +1.98 (+1.91%) At close · Jul 7
Market Cap
$2.42B
Shares
22,850,739

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-05-20 LeMaitre to Participate at Upcoming Investor Conferences in June

BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June. Jefferies Global Healthcare Conference Wednesday, June 3, 2026 Marriott Marquis, New York City Management

2026-05-07 LeMaitre to Present at the Bank of America Healthcare Conference

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT. About LeMaitre LeMaitre is a provider of devices, implants, and services

2026-05-05 LeMaitre Q1 2026 Financial Results

BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. Q1 2026: Sales $66.6mm, +11% (+10% organic) vs.

2026-04-14 LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026

BURLINGTON, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to

2026-04-07 LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference

BURLINGTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2025, at 2:15 PM EDT. About LeMaitre LeMaitre is a provider of devices, implants

2026-02-27 LeMaitre to Participate at Upcoming Investor Conferences in March

BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March. Leerink Partners Global Healthcare Conference Tuesday, March 10, 2026 W South Beach, Miami Management will

2026-02-25 LeMaitre Q4 2025 Financial Results

BURLINGTON, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarterly dividend of $0.25/share (+25%), and provided guidance.

2026-02-11 LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026

BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day

2025-11-12 LeMaitre to Participate in Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London Healthcare Conference 2025 Tuesday, November 18, 2025 Waldorf Hilton, London Dorian LeBlanc, CFO, will

2025-11-06 LeMaitre Q3 2025 Financial Results

BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q3 2025 results include a non-recurring benefit

Past events

Source: https://ir.lemaitre.com/

Key facts CIK 1158895 CUSIP 525558201 13F (30d) 8 filings 8 filers Visit website Investor relations